CFR Expert Discusses Success Of Experimental Ebola Vaccine In DRC

Council on Foreign Relations’ “Africa in Transition”: The Ebola Vaccine Is Highly Effective in Eastern Congo
John Campbell, Ralph Bunche senior fellow for Africa Policy Studies at CFR, discusses the success of an experimental Ebola vaccine developed by Merck & Co being used in the Democratic Republic of the Congo (DRC) outbreak. Campbell says the vaccine’s results are “unalloyed good news” (4/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.